DM
PRAX icon

Deerfield Management’s Praxis Precision Medicines PRAX Stock Holding History

Deerfield Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310M Buy
963,351
+60,000
+7% +$18.6M 3.66% 4
2025
Q4 		$266M Buy
903,351
+62,500
+7% +$11.6M 3.4% 4
2025
Q3 		$44.6M Buy
840,851
+153,920
+22% +$7.46M 0.68% 36
2025
Q2 		$28.9M Buy
686,931
+67,000
+11% +$2.55M 0.52% 38
2025
Q1 		$23.5M Buy
+619,931
New +$38.7M 0.46% 46
2021
Q1 		– Sell
-23,333
Closed -$19.3M – 143
2020
Q4 		$19.3M Buy
+23,333
New +$13.6M 0.38% 72

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management's PRAX Position: Q1 2026 in Review

Deerfield Management increased its Praxis Precision Medicines (PRAX) stake by 6.6% in Q1 2026, buying an estimated $18.6M and bringing the position to 963,351 shares worth $310M. The position accounts for 3.66% of the portfolio, ranked #4.

Deerfield Management first reported a position in PRAX in Q4 2020 and has held it in 6 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Deerfield Management held 963,351 shares of Praxis Precision Medicines worth $310M as of Q1 2026.
  • Deerfield Management bought 60,000 Praxis Precision Medicines shares in Q1 2026, an estimated $18.6M.
  • Praxis Precision Medicines made up 3.66% of Deerfield Management's portfolio in Q1 2026, its #4 holding.
  • Deerfield Management first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 6 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.